PAG
OCUL icon

Private Advisor Group’s Ocular Therapeutix OCUL Stock Holding History

Private Advisor Group’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Buy
+15,688
New +$150K ﹤0.01% 2504
2020
Q3 		– Sell
-2,500
Closed -$21K – 2826
2020
Q2 		$21K Buy
+2,500
New +$16.6K ﹤0.01% 2556

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Private Advisor Group's OCUL Position: Q1 2026 in Review

Private Advisor Group opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 15,688 shares worth $133K. The stake represents ﹤0.01% of the portfolio and ranks #2504 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in OCUL as recently as Q2 2020.

Private Advisor Group first reported a position in OCUL in Q2 2020 and has held it in 2 quarters since. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Private Advisor Group held 15,688 shares of Ocular Therapeutix worth $133K as of Q1 2026.
  • Ocular Therapeutix was a new Private Advisor Group position in Q1 2026.
  • Ocular Therapeutix made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2504 holding.
  • Private Advisor Group first reported a position in Ocular Therapeutix in Q2 2020 and has held it in 2 quarters since.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.